Literature DB >> 29395105

New formula for defining "normal" and "prolonged" QT in patients with bundle branch block.

Lior Yankelson1, Aviram Hochstadt2, Ben Sadeh2, Benley Pick2, Ariel Finkelstein2, Raphael Rosso2, Sami Viskin2.   

Abstract

OBJECTIVES: To predict the QT interval in the presence of normal QRS for patients with left bundle branch block (LBBB).
BACKGROUND: There is no acceptable method for simple and reliable QT correction for patients with bundle branch block (BBB).
METHODS: We measured the QT interval in patients with new onset LBBB who had a recent electrocardiogram with narrow QRS for comparison. 48 patients who developed in-hospital LBBB were studied. Patients who had similar heart rate before and after LBBB were included. We used linear regression, the Bogossian method, and our new fixed QRS replacement method to evaluate the most reliable correction method.
RESULTS: JTc (QTc-QRS) interval was preserved before and after LBBB (328.9 ± 25.4 ms before LBBB vs. 327.3 ms post LBBB (p = 0.550). Mean predicted preLBBB QTc difference was 1.3 ms, -21.3 ms and 1.6 ms for the three methods respectively (p < 0.001 for Bogossian comparison with the other methods). Coefficients of correlation (R) between actual preLBBB QTc with predicted preLBBB QTc were 0.707, 0.683 and 0.665 respectively (p > 0.3 for R comparisons between all methods). The average absolute difference in preLBBB QTc was 15.5 ms and 16.7 ms for the regression and fixed-gender methods (p value between the two = 0.321) and 25.5 ms for the Bogossian method, which was found to be significantly underperforming.
CONCLUSIONS: In patients with LBBB, replacing of the QRS duration after deriving the QTc interval with a fixed value of 88 ms for female and 95 ms for male provides a simple and reliable method for predicting the QTc before the development of LBBB.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  JT; LBBB; QT correction

Mesh:

Year:  2018        PMID: 29395105     DOI: 10.1016/j.jelectrocard.2017.12.039

Source DB:  PubMed          Journal:  J Electrocardiol        ISSN: 0022-0736            Impact factor:   1.438


  4 in total

1.  QT Interval Prolongation Is a Novel Predictor of 1-Year Mortality in Patients With COVID-19 Infection.

Authors:  Ariel Banai; Yishay Szekely; Lior Lupu; Ariel Borohovitz; Erez Levi; Eihab Ghantous; Philippe Taieb; Aviram Hochstadt; Shmuel Banai; Yan Topilsky; Ehud Chorin
Journal:  Front Cardiovasc Med       Date:  2022-06-09

2.  Use of drugs with potential cardiac effect in the setting of SARS-CoV-2 infection.

Authors:  Frederic Sacher; Laurent Fauchier; Serge Boveda; Christian de Chillou; Pascal Defaye; Jean Claude Deharo; Estelle Gandjbakhch; Vincent Probst; Ariel Cohen; Christophe Leclercq
Journal:  Arch Cardiovasc Dis       Date:  2020-04-24       Impact factor: 2.340

3.  COVID-19 therapies and their impact on QT interval prolongation: A multicentre retrospective study on 196 patients.

Authors:  M Bianco; C A Biolè; S Campagnuolo; F Pietrangiolillo; A Spirito; A Galluzzo; I Nuñez-Gil; P Destefanis; A Luciano; P Carvalho; G P Varalda; A Previti; M Gravellone; A Travieso Gonzalez; F Ugo; G Pivano; F Rametta; A Perboni; R Pozzi; L Montagna; E Cerrato
Journal:  Int J Cardiol Heart Vasc       Date:  2020-09-11

4.  The QT Interval Dynamic in a Human Experimental Model of Controlled Heart Rate and QRS Widening.

Authors:  Santiago Colunga; Remigio Padrón; Daniel García-Iglesias; José Manuel Rubín; Diego Pérez; Raquel Del Valle; Pablo Avanzas; César Morís; David Calvo
Journal:  J Clin Med       Date:  2019-09-09       Impact factor: 4.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.